Get the Stockscreener App
34.76
0.87%
0.30
After Hours:
34.90
0.14
+0.40%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $34.76, with a volume of 652.71K.
It is up +0.87% in the last 24 hours and up +7.48% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$34.46
Open:
$34.42
24h Volume:
652.71K
Relative Volume:
0.68
Market Cap:
$1.80B
Revenue:
$225.21M
Net Income/Loss:
$-15.70M
P/E Ratio:
-102.66
EPS:
-0.3386
Net Cash Flow:
$-4.78M
1W Performance:
+2.24%
1M Performance:
+7.48%
6M Performance:
+115.63%
1Y Performance:
+122.11%
1-Day Range:
$34.23
$35.21
1-Week Range:
$31.75
$35.37
52-Week Range:
$9.215
$36.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
34.76 | 1.79B | 225.21M | -15.70M | -4.78M | -0.3386 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Do options traders know something about Axogen stock we don't? - MSN
Assessing Axogen (AXGN) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Axogen, Inc. to Report First Quarter 2026 Financial Results - National Today
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 - The Manila Times
FOMO Trade: Is Axogen Inc stock a good pick for beginners2026 Closing Moves & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Momentum Shift: Is Axogen Inc in a bullish channelPortfolio Return Summary & Real-Time Market Trend Scan - baoquankhu1.vn
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
Trade Recap: How do insiders feel about Axogen Inc2026 Sector Review & Reliable Price Breakout Signals - baoquankhu1.vn
Institution Moves: Is Axogen Inc stock influenced by commodity pricesLayoff News & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Volume Recap: Will Axogen Inc stock go up in YEAR2026 Gainers & Real-Time Buy Signal Notifications - baoquankhu1.vn
Portfolio Shifts: How does Axogen Inc correlate with Nasdaq2026 Earnings Surprises & Technical Analysis for Trade Confirmation - baoquankhu1.vn
AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 earnings call transcript - MSN
AXGN Stock Price $34.00 | AxoGen, Inc. Live Quote - Meyka
Layoff Watch: How does Axogen Inc correlate with NasdaqDay Trade & Safe Capital Allocation Plans - baoquankhu1.vn
Aug Analyst Calls: Will Axogen Inc stock go up in YEAR2026 Weekly Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
F&V Capital Management, LLC's Axogen Inc(AXGN) Holding History - GuruFocus
Is Axogen (AXGN) Quietly Redefining Nerve Repair Moats With Avance and New Portfolio Backing? - simplywall.st
AxoGen (NASDAQ:AXGN) Shares Down 4.4%Here's Why - MarketBeat
SG Americas Securities LLC Increases Stock Holdings in AxoGen, Inc. $AXGN - marketbeat.com
AxoGen, Inc. $AXGN Shares Sold by JPMorgan Chase & Co. - MarketBeat
AXGN PE Ratio & Valuation, Is AXGN Overvalued - Intellectia AI
What Makes Axogen (AXGN) an Investment Bet? - Insider Monkey
F&V Capital Management LLC Purchases Shares of 176,995 AxoGen, Inc. $AXGN - MarketBeat
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know - AOL.com
Income Plays: Is Axogen Inc attractive at current valuation2026 News Drivers & Weekly Momentum Picks - baoquankhu1.vn
AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | - GuruFocus
Risk Recap: Is Axogen Inc in a bullish channel2026 Technical Patterns & Weekly Breakout Stock Alerts - baoquankhu1.vn
AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | AXGN Stock News - gurufocus.com
AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group - marketbeat.com
Trading Recap: Is Axogen Inc stock influenced by commodity pricesBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
(AXGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Nasdaq Moves: How correlated is Axogen Inc to the S P5002026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth - AOL.com
AxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Vanguard realigns reporting; Axogen (NASDAQ: AXGN) shows 0 shares owned - Stock Titan
Assenagon Asset Management S.A. Purchases 90,777 Shares of AxoGen, Inc. $AXGN - marketbeat.com
DAFNA Capital Management Sells Axogen Shares in 2025News and Statistics - IndexBox
This $6.5 Million Healthcare Reduction Follows a 71% Increase in Stock Price and 20% Rise in Revenue - Bitget
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):